Mercedes Armand‐Ugón

Author

Hospital Universitari Germans Trias i Pujol ORCID

Also Known As

Armand-Ugon, M., M ARMANDUGON, M. Armand-Ugon, Mercedes Armand-Ugon, Mercedes Armand-Ugón, Mercedes Armand-Ugón, Mercedes Armand-Úgon, Mercedes Armand‐Ugon, Mercedes Armand‐Ugón

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari Germans Trias i Pujol Universitat Autònoma de Barcelona Universitat de Barcelona IrsiCaixa University of Siena

About

Mercedes Armand‐Ugón is an author at Hospital Universitari Germans Trias i Pujol specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	902
2	Natural Sciences	5	5	158
3	Biochemistry	5	5	158
4	Social Sciences	1	1	41
5	Allergy	1	1	27

Mercedes Armand‐Ugón

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Functional Differences between the Long Terminal Repeat Transcriptional Promoters of Human Immunodeficiency Virus Type 1 Subtypes A through G Rienk E. Jeeninga, Maarten Hoogenkamp, Mercedes Armand‐Ugón, Journal of Virology	2000	293
Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication Miguel Ángel Martı́nez, Arantxa Gutiérrez, Mercedes Armand‐Ugón, AIDS Viral ReplicationBase Pair RnaChemokine Receptor ExpressionRna InterferenceHuman Retrovirus	2002	239
Cell-Surface-Expressed HIV-1 Envelope Induces the Death of CD4 T Cells during GP41-Mediated Hemifusion-like Events Julià Blanco, Jordi Barretina, Karine F. Ferri, Virology Human RetrovirusCell-surface-expressed Hiv-1 EnvelopeGp41-mediated Hemifusion-like EventsImmunologyAntiviral Response	2003	73
Neuroinflammatory Gene Regulation, Mitochondrial Function, Oxidative Stress, and Brain Lipid Modifications With Disease Progression in Tau P301S Transgenic Mice as a Model of Frontotemporal Lobar Degeneration-Tau Irene López‐González, Ester Aso, Margarita Carmona, Journal of Neuropathology & Experimental Neurology Tau OligomersBrain Lipid ModificationsTau TruncationPs19 LineGenetics	2015	73
HIV-1 resistance to the gp41-dependent fusion inhibitor C-34 Mercedes Armand‐Ugón, Arantxa Gutiérrez, Bonaventura Clotet, Antiviral Research Hiv-1 ResistanceMedicineHuman RetrovirusImmunologyAntiviral Response	2003	63
Reduced Mitochondrial Activity is Early and Steady in the Entorhinal Cortex but it is Mainly Unmodified in the Frontal Cortex in Alzheimer's Disease Mercedes Armand‐Ugón, Belén Ansoleaga, Sara Berjaoui, Current Alzheimer Research	2017	58
Synthesis and Biological Properties of Novel 2-Aminopyrimidin-4(3<i>H</i>)-ones Highly Potent against HIV-1 Mutant Strains Antonello Mai, Marino Artico, Dante Rotili, Journal of Medicinal Chemistry Combinatorial ChemistryWt Hiv-1Biological PropertiesOrganic ChemistryPeptide Science	2007	54
HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro Gemma Moncunill, Mercedes Armand‐Ugón, Eduardo Pauls, AIDS	2008	54
Anti-HIV Activity and Resistance Profile of the CXC Chemokine Receptor 4 Antagonist POL3026 Gemma Moncunill, Mercedes Armand‐Ugón, Imma Clotet‐Codina, Molecular Pharmacology	2008	52
5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3<i>H</i>)-ones, a Series of Anti-HIV-1 Agents of the Dihydro-alkoxy-benzyl-oxopyrimidine Family with Peculiar Structure−Activity Relationship Profile Maxim B. Nawrozkij, Dante Rotili, Domenico Tarantino, Journal of Medicinal Chemistry	2008	51

Page 1